論文・技術情報追加のお知らせ

czeekv

3日前

論文・技術情報追加のお知らせ

2024年11月24日～2024年11月30日の間に収集した論文情報を追加しました。

1. JAK Inhibitors: A Double-Edged Sword in Immune-Mediated Diseases Management.

JAK阻害薬の副作用、特に消化管穿孔や癌のリスク

対象DB：FAERS

2. Anaphylactic risk associated with iodinated and gadolinium-based contrast media.

造影剤によるアナフィラキシーのリスクを分析

対象DB：FAERS

3. Advanced AI-Driven Prediction of Pregnancy-Related Adverse Drug Reactions.

妊娠中のADR予測にDMPNNモデルが有効

対象DB：FAERS

4. Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis.

GLP-1 RAsと急性膵炎の関連性をFAERSで分析

対象DB：FAERS

5. Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database.

DMARDsと悪性腫瘍の関連性をFAERSで分析

対象DB：FAERS

6. Disproportionality analysis of adverse events associated with asfotase alfa: a post-marketing study using the FDA Adverse Event Reporting System.

アスフォターゼアルファの副作用分析と安全性評価

対象DB：FAERS

7. A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database.

ティルゼパチドの副作用シグナルと安全性分析

対象DB：FAERS

8. A real-world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib.

プラルセチニブの副作用シグナルとリスク分析

対象DB：FAERS

9. A Disproportionality Analysis of Treprostinil Based on FDA Adverse Event Reporting System Database.

FDAデータベースを用いたトレプロスチニルの副作用分析

対象DB：FAERS

10. Investigating Osteomyelitis as a Rare Adverse Effect of Vaccination in the Pediatric Population.

予防接種後の小児骨髄炎の報告と関連性

対象DB：FAERS,VAERS

11. Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review.

EoE治療におけるモノクローナル抗体の安全性と効果

対象DB：FAERS

12. Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database.

ナルコレプシー薬の安全性を確認するための分析

対象DB：FAERS

13. Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis.

免疫チェックポイント阻害薬による遅発性免疫関連有害事象の分析

対象DB：FAERS

14. Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database.

トリプタン系薬剤の副作用に関する実データ分析

対象DB：FAERS

15. Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database.

GLP-1受容体作動薬と眼科的副作用の関連調査

対象DB：FAERS

16. Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system.

GLP-1受容体作動薬と胃排出遅延の関連調査

対象DB：FAERS

17. Drug-induced Kounis Syndrome: A Retrospective Pharmacovigilance Study from the FAERS and JADER Databases.

薬物誘発性クーニス症候群に関する調査

対象DB：JADER

18. Building a Stronger Backbone: 3D Printing's Role in Treating Spinal Cord Conditions.

3Dプリンティング技術は脊髄損傷治療に有望

対象DB：JADER

19. Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression.

エスケタミン使用後の呼吸抑制は稀だが、監視が推奨

対象DB：EudraVigilance

20. Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2).

セルリポナーゼアルファの副作用は発熱やけいれん、さらに調査が必要

対象DB：EudraVigilance

21. The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity.

CAPは心毒性、特に心筋梗塞や心不全に関連

対象DB：EudraVigilance

AK阻害薬で骨折リスク増加、クラス効果の可能性あり

対象DB：VigiBase

23. Analysis of Adverse Reactions Associated with the Use of Crataegus-Containing Herbal Products.

Crataegus製品は軽度の副作用があるが、安全性は高い

対象DB：VigiBase

24. Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection.

上部消化管ESDにはリバーロキサバンが最適、脳梗塞と遅発性出血リスク低減

対象DB：DPC

25. Effects of Reablement on the Independence of Community-Dwelling Older Adults with Mild Disability: A Randomized Controlled Trial.

高齢者の軽度障害者に対し、CoMMITプログラムが介護依存度低減に効果

対象DB：JMDC

26. Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase窶善ositive Non窶壮mall Cell Lung Cancer in Japan.

ALK陽性肺癌にICIの効果限定的、治療中断中央値66日

対象DB：MDV

27. Potential interactions between direct oral anticoagulants and atorvastatin/simvastatin: cohort and case-crossover study.

DOACとスタチン併用で出血・死亡リスク増、特に開始時注意

対象DB：CPRD

28. Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z-Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK Clinical Practice Research Datalink.

重症患者の5%が新規ベンゾジアゼピン処方を受ける

対象DB：CPRD

29. Epidemiology of Childhood Asthma in the UK.

小児喘息の有病率6.5%、重症度で症状と併存疾患が悪化

対象DB：CPRD

30. Incidence of side effects associated with acetaminophen in people aged 65 years or more: a prospective cohort study using data from the Clinical Practice Research Datalink.

高齢者のアセトアミノフェン使用で消化管出血などリスク増加

対象DB：CPRD

31. Home care program and exercise prescription for improving quality of life in geriatric population with knee osteoarthritis: A systematic review and meta-analysis.

自宅ケアと運動療法で高齢者の膝OA生活の質が改善

対象DB：DeSC